Yuehua Li Selected Research

Lipopolysaccharides

1/2020	HSPA12A attenuates lipopolysaccharide-induced liver injury through inhibiting caspase-11-mediated hepatocyte pyroptosis via PGC-1α-dependent acyloxyacyl hydrolase expression.
12/2015	HSPA12B attenuates acute lung injury during endotoxemia in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yuehua Li Research Topics

Disease

21	Neoplasms (Cancer) 10/2022 - 12/2011
13	Inflammation (Inflammations) 01/2021 - 05/2007
9	Cardiomegaly (Heart Hypertrophy) 01/2016 - 10/2004
8	Breast Neoplasms (Breast Cancer) 01/2022 - 06/2017
8	Hemorrhagic Shock 01/2015 - 05/2007
7	Ischemic Stroke 08/2022 - 05/2008
7	Stroke (Strokes) 02/2022 - 05/2008
6	Sepsis (Septicemia) 10/2022 - 12/2009
6	Neoplasm Metastasis (Metastasis) 06/2021 - 07/2016
5	Wounds and Injuries (Trauma) 11/2017 - 12/2009
4	Body Weight (Weight, Body) 01/2018 - 10/2004
4	Fibrosis (Cirrhosis) 12/2017 - 03/2006
4	Ischemia 01/2016 - 05/2007
3	Atherosclerosis 01/2022 - 02/2013
3	Acute Lung Injury 12/2021 - 12/2009
3	Pathologic Constriction (Stenosis) 06/2021 - 01/2018
3	Carcinogenesis 01/2021 - 07/2016
3	Endolymphatic Hydrops 10/2020 - 02/2014
3	Myocardial Ischemia (Ischemic Heart Diseases) 01/2020 - 05/2009
3	Pneumonia (Pneumonitis) 01/2020 - 08/2007
3	Hypoxia (Hypoxemia) 07/2019 - 01/2017
3	Reperfusion Injury 01/2017 - 05/2009
3	Shock 03/2011 - 04/2006
2	Liver Neoplasms (Liver Cancer) 07/2022 - 01/2018
2	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2022 - 01/2021
2	Thrombosis (Thrombus) 02/2022 - 01/2021
2	Gallbladder Neoplasms (Gallbladder Cancer) 01/2022 - 07/2016
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 01/2020
2	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 05/2020
2	Type 2 Diabetes Mellitus (MODY) 05/2020 - 01/2020
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 05/2009
2	Cerebral Infarction 01/2020 - 05/2008
2	Infections 01/2020 - 01/2020
2	Obesity 11/2019 - 07/2016
2	Infarction (Infarctions) 05/2018 - 09/2009
2	AIDS-Related Complex (ARC) 01/2018 - 09/2017
2	Insulin Resistance 01/2017 - 01/2013
2	Myocardial Infarction 01/2017 - 11/2012
2	Coronary Disease (Coronary Heart Disease) 01/2017 - 06/2013
2	Hypertrophy 01/2016 - 05/2015
2	Cardiomyopathies (Cardiomyopathy) 07/2015 - 05/2015
2	Optic Nerve Injuries 07/2014 - 07/2011
2	Hemorrhage 12/2009 - 05/2007

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2009
8	Small Interfering RNA (siRNA)IBA 01/2022 - 03/2015
7	Long Noncoding RNAIBA 01/2022 - 06/2017
7	Biomarkers (Surrogate Marker)IBA 01/2021 - 02/2013
7	CytokinesIBA 01/2021 - 08/2007
6	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2022 - 05/2007
6	NF-kappa B (NF-kB)IBA 12/2009 - 10/2004
5	InflammasomesIBA 04/2022 - 11/2011
5	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2021 - 12/2009
5	NADPH Oxidases (NAD(P)H oxidase)IBA 11/2017 - 05/2007
4	Pharmaceutical PreparationsIBA 01/2022 - 01/2018
4	Nucleic AcidsIBA 01/2022 - 10/2020
4	Heat-Shock Proteins (Heat-Shock Protein)IBA 02/2021 - 12/2015
4	Sirtuin 1IBA 07/2019 - 01/2017
4	salicylhydroxamic acid (SHAM)IBA 07/2011 - 10/2004
3	Biological ProductsIBA 07/2022 - 01/2020
3	Circular RNAIBA 01/2021 - 01/2020
3	Therapeutic UsesIBA 01/2021 - 07/2011
3	Pregnancy-Associated Plasma Protein-A (PAPP-A)IBA 01/2020 - 02/2013
3	CollagenIBA 12/2017 - 04/2014
3	Phosphotransferases (Kinase)IBA 01/2016 - 07/2014
3	LigandsIBA 11/2014 - 05/2007
2	Interleukin-33IBA 10/2022 - 01/2018
2	FibrinIBA 02/2022 - 01/2021
2	Photosensitizing Agents (Photosensitizers)IBA 01/2022 - 03/2021
2	polyethylene glycol polyethyleneimine nanogelIBA 01/2022 - 07/2021
2	Sirolimus (Rapamycin)FDA Link 01/2022 - 12/2005
2	LeptinIBA 01/2022 - 07/2016
2	AntioxidantsIBA 01/2021 - 10/2004
2	AntigensIBA 10/2020 - 10/2004
2	Glycerol (Glycerine)FDA LinkGeneric 10/2020 - 01/2018
2	LipopolysaccharidesIBA 01/2020 - 12/2015
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 11/2019 - 08/2012
2	Retinaldehyde (Retinal)IBA 07/2019 - 01/2019
2	CalciumIBA 01/2018 - 09/2017
2	NucleotidesIBA 01/2018 - 11/2014
2	Estrogens (Estrogen)FDA Link 01/2018 - 08/2009
2	SolutionsIBA 09/2017 - 05/2015
2	Histones (Histone)IBA 01/2017 - 01/2017
2	HSP27 Heat-Shock ProteinsIBA 01/2016 - 07/2015
2	EndotoxinsIBA 12/2015 - 05/2007
2	Angiopoietin-1IBA 04/2015 - 11/2012
2	ChemokinesIBA 07/2013 - 08/2007
2	NADP (NADPH)IBA 03/2011 - 08/2007
2	HMGB1 Protein (HMG1)IBA 12/2009 - 05/2007
2	Toll-Like Receptors (Toll-Like Receptor)IBA 08/2007 - 11/2005
2	prolinedithiocarbamate (PDTC)IBA 12/2005 - 10/2004

Therapy/Procedure

9	Therapeutics 08/2022 - 02/2014
5	Resuscitation 11/2014 - 05/2007
3	Punctures 10/2022 - 01/2018
3	Ligation 10/2022 - 01/2018
3	Stents 02/2022 - 06/2018
3	Thrombectomy 02/2022 - 01/2021
2	Immunotherapy 07/2021 - 01/2020
2	Intraperitoneal Injections 01/2021 - 07/2014
2	Drug Therapy (Chemotherapy) 05/2020 - 02/2018
2	Radiotherapy 01/2020 - 12/2011